Glendon French

Glendon E.
French was the founder of Broncus Technologies, Inc., founded in 1997, where the title held was Director from 1997 to 2011.
Mr. French was also the founder of NDO Surgical, Inc...
Mr. French previously served as President, Chief Executive Officer & Director at Pulmonx Corp.
since 2014.
Also holds Director positions at RadioTherapeutics Corp, CoLabs, Inc. (since 2025), and Myka Labs, Inc. (since 2024).
Former positions include Chairman, Chief Executive Officer & Director at Applied Immune Sciences, Inc. (1989–1992); President, Chief Executive Officer & Director at Asthmatx, Inc. (2003–2010); Chairman & Chief Executive Officer at Imagyn Medical, Inc. (1992–1994); Chief Executive Officer & Director at ApniCure, Inc. (2014); Executive Chairman at Levita Magnetics International Corp.
(2013–2022); Vice President-Marketing at C.
R.
Bard, Inc. (1993–1997); President-Pulmonary Endoscopy at Boston Scientific Corp.
(2010–2012); President-Health & Education Sector at Aramark Services, Inc. (1988); and President at Dupont Critical Care, Inc. Also held Director roles at Pacific Physician Services, Inc., AMO Manufacturing USA LLC, Percutaneous Systems, Inc., Webster Laboratories, Inc., LPL Technologies, Inc., Michigan Bank, FSB (Troy, Michigan), and Independent Director at EDAP TMS SA (2025–2026).
Education includes undergraduate studies at Dartmouth College and an MBA from The Wharton School of the University of Pennsylvania.